Design, reporting, and research focus of neurology and psychiatry drug trials (2020-2023): a registry-based meta-epidemiological study using ClinicalTrials.gov and NLP
CONCLUSIONS: Registered neurology and psychiatry drug trials show persistent limitations in design and results reporting despite two decades of registry requirements.
PubMed - AI Research2 min read